These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12135284)

  • 21. Treatment of visceral leishmaniasis with amphotericin B colloidal dispersion.
    Berman J; Dietze R
    Chemotherapy; 1999 Jun; 45 Suppl 1():54-66. PubMed ID: 10394022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observations on amphotericin B treatment of kala-azar given in a rural set up in Bihar, India.
    Thakur CP; Ahmed S
    Indian J Med Res; 2001 Jan; 113():14-8. PubMed ID: 11280166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony.
    Sundar S; Agrawal NK; Sinha PR; Horwith GS; Murray HW
    Ann Intern Med; 1997 Jul; 127(2):133-7. PubMed ID: 9230003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study.
    Thakur CP
    Int J Antimicrob Agents; 2001 Jan; 17(1):67-70. PubMed ID: 11137652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A curative immune profile one week after treatment of Indian kala-azar patients predicts success with a short-course liposomal amphotericin B therapy.
    Mondal S; Bhattacharya P; Rahaman M; Ali N; Goswami RP
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e764. PubMed ID: 20668544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study.
    Sundar S; Jha TK; Thakur CP; Mishra M; Singh VP; Buffels R
    Clin Infect Dis; 2003 Sep; 37(6):800-4. PubMed ID: 12955641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine.
    Sundar S; Rai M; Chakravarty J; Agarwal D; Agrawal N; Vaillant M; Olliaro P; Murray HW
    Clin Infect Dis; 2008 Oct; 47(8):1000-6. PubMed ID: 18781879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children.
    Apa H; Devrim İ; Bayram N; Deveci R; Demir-Özek G; Cartı ÖU
    Turk J Pediatr; 2013; 55(4):378-83. PubMed ID: 24292030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh.
    Sundar S; Pandey K; Mondal D; Madhukar M; Kamal Topno R; Kumar A; Kumar V; Kumar Verma D; Chakravarty J; Chaubey R; Kumari P; Rashid MU; Maruf S; Ghosh P; Raja S; Rode J; den Boer M; Das P; Alvar J; Rijal S; Alves F
    PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012242. PubMed ID: 38900786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia.
    Tamiru A; Tigabu B; Yifru S; Diro E; Hailu A
    BMC Infect Dis; 2016 Oct; 16(1):548. PubMed ID: 27724891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL).
    Musa AM; Khalil EA; Mahgoub FA; Hamad S; Elkadaru AM; El Hassan AM
    Ann Trop Med Parasitol; 2005 Sep; 99(6):563-9. PubMed ID: 16156969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphotericin B for treatment of visceral leishmaniasis: systematic review and meta-analysis of prospective comparative clinical studies including dose-ranging studies.
    Rodrigo C; Weeratunga P; Fernando SD; Rajapakse S
    Clin Microbiol Infect; 2018 Jun; 24(6):591-598. PubMed ID: 29138100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-dose indigenous liposomal amphotericin B in the treatment of Indian visceral leishmaniasis: a phase 2 study.
    Sundar S; Singh A; Rai M; Chakravarty J
    Am J Trop Med Hyg; 2015 Mar; 92(3):513-7. PubMed ID: 25510715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis.
    Bodhe PV; Kotwani RN; Kirodian BG; Pathare AV; Pandey AK; Thakur CP; Kshirsagar NA
    Trans R Soc Trop Med Hyg; 1999; 93(3):314-8. PubMed ID: 10492769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?
    Salih NA; van Griensven J; Chappuis F; Antierens A; Mumina A; Hammam O; Boulle P; Alirol E; Alnour M; Elhag MS; Manzi M; Kizito W; Zachariah R
    Trop Med Int Health; 2014 Feb; 19(2):146-52. PubMed ID: 24433217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized comparison of classical mode of administration of amphotericin B with its newer modes of administration in kala-azar.
    Thakur CP; Kumar P; Kumar N; Singh GN; Singh AK; Narain S
    J Assoc Physicians India; 1998 Sep; 46(9):779-83. PubMed ID: 11229246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of Single-Dose Liposomal Amphotericin B in Visceral Leishmaniasis in Bihar.
    Sundar S; Singh A; Agrawal N; Chakravarty J
    Am J Trop Med Hyg; 2019 Oct; 101(4):795-798. PubMed ID: 31436156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions.
    Sundar S; Chakravarty J; Rai VK; Agrawal N; Singh SP; Chauhan V; Murray HW
    Clin Infect Dis; 2007 Sep; 45(5):556-61. PubMed ID: 17682988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis.
    Sundar S; Goyal AK; Mandal AK; Makharia MK; Singh VP; Murray HW
    J Assoc Physicians India; 1999 Feb; 47(2):186-8. PubMed ID: 10999086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year field results and long-term effectiveness of 20 mg/kg liposomal amphotericin B (Ambisome) for visceral leishmaniasis in Bihar, India.
    Burza S; Sinha PK; Mahajan R; Lima MA; Mitra G; Verma N; Balasegaram M; Das P
    PLoS Negl Trop Dis; 2014; 8(1):e2603. PubMed ID: 24392168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.